Cite
APA Citation
Reches, A., Ophir, Y., Stein, N., Kol, I., Isaacson, B., Charpak Amikam, Y., Elnekave, A., Tsukerman, P., Kucan Brlic, P., Lenac, T., Seliger, B., Jonjic, S., & Mandelboim, O. (2020). nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity. Journal for immunotherapy of cancer, 8(1), . http://access.bl.uk/ark:/81055/vdc_100127572798.0x000037